COOThe Cooper Companies
The financials
The Cooper Companies by the numbers
The Cooper Companies (COO) reported revenue of $1.07B in Q3 2026 (quarter ended Jul 31, 2026), up 0.6% from the same quarter a year earlier. That came with a gross margin of 67% and net income of $433M (41% of revenue). For the full year FY2025, revenue was $4.09B (+5.1% year on year) and net income $375M. Its largest product in Q2 2026 (quarter ended Apr 30, 2026) was Toric And Multifocal at $365M, 34% of the disclosed total, just ahead of Sphere Other at 33%. The next results filing is expected around Dec 3, 2026, the same week as a year ago.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $1.07B | $1.06B | +0.6% |
| Gross profit | $712M | $692M | +2.9% |
| Operating income | $222M | $176M | +26% |
| Net income | $433M | $98M | +340% |
| Diluted EPS | $2.24 | $0.49 | +357% |
| Product | Revenue | Share |
|---|---|---|
| Toric And Multifocal | $365M | 34% |
| Sphere Other | $359M | 33% |
| Office And Surgical | $214M | 20% |
| Fertility | $144M | 13% |
Over its last three fiscal years The Cooper Companies booked income tax of 32.0% of its pretax profit, 12.9% once deferred tax is taken out, above the 21.3% median for US companies in our tax study.
Business segments
Revenue split by product segment, from SEC XBRL filings.
- Toric And Multifocal$364.9M$364.9Mvs last quarter +3.9%vs a year ago +11%+3.9%+11%
- Sphere Other$358.6M$358.6Mvs last quarter +4.3%vs a year ago +5.1%+4.3%+5.1%
- Office And Surgical$214.2M$214.2Mvs last quarter +5.8%vs a year ago +4.1%+5.8%+4.1%
- Fertility$143.8M$143.8Mvs last quarter +14%vs a year ago +13%+14%+13%
Medical Instruments & Supplies
The closest names by size in the same industry